跳至主要内容
临床试验/CTRI/2023/02/050141
CTRI/2023/02/050141尚未招募3 期

Randomized controlled clinical trial to study efficay of ashwagandharishta and polybion syrup in early presbyacusis in improving speech discrimination score.

Tilak Ayurveda Mahavidyalaya1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2023年2月28日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
44
试验地点
1
主要终点
Sample size 44 improvement in speech discrimination score

研究概览

简要总结

The study will be intervened by the treatment of ashwagandharishta and polybion syrup to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective criteria for statistical analysis. Scoring will be designed according to improvement in speech discrimination score. The speech discrimination score will be calculated before treatment, during treatment and after treatment. The effect of treatment results will be assessed in regard to improvement in speech discrimination score.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Not Applicable

入排标准

年龄范围
40.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients having presbyacusis.
  • Patients ready to give consent.

排除标准

  • Patients having history of immunosuppresant disorder.
  • patients having perforated tympanic membrane.
  • Patients having hearing aid.

结局指标

主要结局

Sample size 44 improvement in speech discrimination score

时间窗: 3 months

次要结局

  • Sample size 44 improvement in speech discrimination score(6 months)

研究者

发起方
Tilak Ayurveda Mahavidyalaya
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验